Caplin Point Laboratories Ltd consolidated Q3 FY2023 net profit up at Rs. 97.48 crores

Caplin Point Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 386.22 crores during the period ended December 31, 2022 as compared to Rs. 375.53 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 97.48 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 91.67 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 12.75 for the period ended December 31, 2022 as compared to Rs. 11.99 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹386.22 crs	₹375.53 crs	2.85%
Net Profit	₹97.48 crs	₹91.67 crs	6.34%
EPS	₹12.75	₹11.99	6.34%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.386.22 crores during the period ended December 31, 2022 as compared to Rs.335.74 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.97.48 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.74.95 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.12.75 for the period ended December 31, 2022 as compared to Rs.9.81 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹386.22 crs	₹335.74 crs	15.04%
Net Profit	₹97.48 crs	₹74.95 crs	30.06%
EPS	₹12.75	₹9.81	29.97%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.1122.03 crores during the 9 Months period ended December 31, 2022 as compared to Rs.957.41 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.274.16 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.220.78 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.35.85 for the 9 Months period ended December 31, 2022 as compared to Rs.28.92 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹1122.03 crs	₹957.41 crs	17.19%
Net Profit	₹274.16 crs	₹220.78 crs	24.18%
EPS	₹35.85	₹28.92	23.96%

Shares of Caplin Point Laboratories Limited was last trading in BSE at Rs. 712.50 as compared to the previous close of Rs. 704.40. The total number of shares traded during the day was 4742 in over 512 trades.

The stock hit an intraday high of Rs. 716.45 and intraday low of 703.30. The net turnover during the day was Rs. 3373493.00.

Source : Equity Bulls

Keywords

CaplinPointLaboratories Q3FY23 9MFY23 ResultUpdate